Financhill
Buy
56

LABD Quote, Financials, Valuation and Earnings

Last price:
$9.54
Seasonality move :
-28.39%
Day range:
$8.19 - $9.57
52-week range:
$4.78 - $16.05
Dividend yield:
3.43%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
22.6M
Avg. volume:
11.5M
1-year change:
17.44%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
LABD
Direxion Daily S&P Biotech Bear 3X Shares
-- -- -- -- --
DRV
Direxion Daily Real Estate Bear 3X Shares
-- -- -- -- --
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
-- -- -- -- --
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
-- -- -- -- --
TECS
Direxion Daily Technology Bear 3x Shares
-- -- -- -- --
WEBS
Direxion Daily Dow Jones Internet Bear 3X Shares
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
LABD
Direxion Daily S&P Biotech Bear 3X Shares
$9.56 -- -- -- $0.05 3.43% --
DRV
Direxion Daily Real Estate Bear 3X Shares
$25.71 -- -- -- $0.28 4.88% --
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
$6.75 -- -- -- $0.10 5.43% --
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
$17.26 -- -- -- $0.23 5.48% --
TECS
Direxion Daily Technology Bear 3x Shares
$44.35 -- -- -- $0.47 5.32% --
WEBS
Direxion Daily Dow Jones Internet Bear 3X Shares
$30.38 -- -- -- $0.22 7.39% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
LABD
Direxion Daily S&P Biotech Bear 3X Shares
-- -5.317 -- --
DRV
Direxion Daily Real Estate Bear 3X Shares
-- -3.831 -- --
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
-- -0.841 -- --
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
-- -4.762 -- --
TECS
Direxion Daily Technology Bear 3x Shares
-- -3.725 -- --
WEBS
Direxion Daily Dow Jones Internet Bear 3X Shares
-- -3.832 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
LABD
Direxion Daily S&P Biotech Bear 3X Shares
-- -- -- -- -- --
DRV
Direxion Daily Real Estate Bear 3X Shares
-- -- -- -- -- --
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
-- -- -- -- -- --
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
-- -- -- -- -- --
TECS
Direxion Daily Technology Bear 3x Shares
-- -- -- -- -- --
WEBS
Direxion Daily Dow Jones Internet Bear 3X Shares
-- -- -- -- -- --

Direxion Daily S&P Biotech Bear 3X Shares vs. Competitors

  • Which has Higher Returns LABD or DRV?

    Direxion Daily Real Estate Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Real Estate Bear 3X Shares's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- --
    DRV
    Direxion Daily Real Estate Bear 3X Shares
    -- -- --
  • What do Analysts Say About LABD or DRV?

    Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Real Estate Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Real Estate Bear 3X Shares.

    Company Buy Ratings Hold Ratings Sell Ratings
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    0 0 0
    DRV
    Direxion Daily Real Estate Bear 3X Shares
    0 0 0
  • Is LABD or DRV More Risky?

    Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Real Estate Bear 3X Shares has a beta of -3.246, suggesting its less volatile than the S&P 500 by 424.55%.

  • Which is a Better Dividend Stock LABD or DRV?

    Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.43%. Direxion Daily Real Estate Bear 3X Shares offers a yield of 4.88% to investors and pays a quarterly dividend of $0.28 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Real Estate Bear 3X Shares pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LABD or DRV?

    Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Real Estate Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Real Estate Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Real Estate Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- -- --
    DRV
    Direxion Daily Real Estate Bear 3X Shares
    -- -- -- --
  • Which has Higher Returns LABD or EDZ?

    Direxion Daily MSCI Emerging Markets Bear 3x Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily MSCI Emerging Markets Bear 3x Shs's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- --
    EDZ
    Direxion Daily MSCI Emerging Markets Bear 3x Shs
    -- -- --
  • What do Analysts Say About LABD or EDZ?

    Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Emerging Markets Bear 3x Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily MSCI Emerging Markets Bear 3x Shs, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily MSCI Emerging Markets Bear 3x Shs.

    Company Buy Ratings Hold Ratings Sell Ratings
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    0 0 0
    EDZ
    Direxion Daily MSCI Emerging Markets Bear 3x Shs
    0 0 0
  • Is LABD or EDZ More Risky?

    Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily MSCI Emerging Markets Bear 3x Shs has a beta of -2.360, suggesting its less volatile than the S&P 500 by 335.996%.

  • Which is a Better Dividend Stock LABD or EDZ?

    Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.43%. Direxion Daily MSCI Emerging Markets Bear 3x Shs offers a yield of 5.43% to investors and pays a quarterly dividend of $0.10 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily MSCI Emerging Markets Bear 3x Shs pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LABD or EDZ?

    Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily MSCI Emerging Markets Bear 3x Shs quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily MSCI Emerging Markets Bear 3x Shs's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily MSCI Emerging Markets Bear 3x Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily MSCI Emerging Markets Bear 3x Shs. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- -- --
    EDZ
    Direxion Daily MSCI Emerging Markets Bear 3x Shs
    -- -- -- --
  • Which has Higher Returns LABD or HIBS?

    Direxion Daily S&P 500 High Beta Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily S&P 500 High Beta Bear 3X Shares's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- --
    HIBS
    Direxion Daily S&P 500 High Beta Bear 3X Shares
    -- -- --
  • What do Analysts Say About LABD or HIBS?

    Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P 500 High Beta Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily S&P 500 High Beta Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily S&P 500 High Beta Bear 3X Shares.

    Company Buy Ratings Hold Ratings Sell Ratings
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    0 0 0
    HIBS
    Direxion Daily S&P 500 High Beta Bear 3X Shares
    0 0 0
  • Is LABD or HIBS More Risky?

    Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily S&P 500 High Beta Bear 3X Shares has a beta of -4.316, suggesting its less volatile than the S&P 500 by 531.574%.

  • Which is a Better Dividend Stock LABD or HIBS?

    Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.43%. Direxion Daily S&P 500 High Beta Bear 3X Shares offers a yield of 5.48% to investors and pays a quarterly dividend of $0.23 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily S&P 500 High Beta Bear 3X Shares pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LABD or HIBS?

    Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily S&P 500 High Beta Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily S&P 500 High Beta Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily S&P 500 High Beta Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily S&P 500 High Beta Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- -- --
    HIBS
    Direxion Daily S&P 500 High Beta Bear 3X Shares
    -- -- -- --
  • Which has Higher Returns LABD or TECS?

    Direxion Daily Technology Bear 3x Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Technology Bear 3x Shares's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- --
    TECS
    Direxion Daily Technology Bear 3x Shares
    -- -- --
  • What do Analysts Say About LABD or TECS?

    Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Technology Bear 3x Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Technology Bear 3x Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Technology Bear 3x Shares.

    Company Buy Ratings Hold Ratings Sell Ratings
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    0 0 0
    TECS
    Direxion Daily Technology Bear 3x Shares
    0 0 0
  • Is LABD or TECS More Risky?

    Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Technology Bear 3x Shares has a beta of -3.498, suggesting its less volatile than the S&P 500 by 449.775%.

  • Which is a Better Dividend Stock LABD or TECS?

    Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.43%. Direxion Daily Technology Bear 3x Shares offers a yield of 5.32% to investors and pays a quarterly dividend of $0.47 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Technology Bear 3x Shares pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LABD or TECS?

    Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Technology Bear 3x Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Technology Bear 3x Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Technology Bear 3x Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Technology Bear 3x Shares. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- -- --
    TECS
    Direxion Daily Technology Bear 3x Shares
    -- -- -- --
  • Which has Higher Returns LABD or WEBS?

    Direxion Daily Dow Jones Internet Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Dow Jones Internet Bear 3X Shares's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- --
    WEBS
    Direxion Daily Dow Jones Internet Bear 3X Shares
    -- -- --
  • What do Analysts Say About LABD or WEBS?

    Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Dow Jones Internet Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Dow Jones Internet Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Dow Jones Internet Bear 3X Shares.

    Company Buy Ratings Hold Ratings Sell Ratings
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    0 0 0
    WEBS
    Direxion Daily Dow Jones Internet Bear 3X Shares
    0 0 0
  • Is LABD or WEBS More Risky?

    Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Dow Jones Internet Bear 3X Shares has a beta of -3.531, suggesting its less volatile than the S&P 500 by 453.08%.

  • Which is a Better Dividend Stock LABD or WEBS?

    Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.43%. Direxion Daily Dow Jones Internet Bear 3X Shares offers a yield of 7.39% to investors and pays a quarterly dividend of $0.22 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Dow Jones Internet Bear 3X Shares pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LABD or WEBS?

    Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Dow Jones Internet Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Dow Jones Internet Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Dow Jones Internet Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Dow Jones Internet Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LABD
    Direxion Daily S&P Biotech Bear 3X Shares
    -- -- -- --
    WEBS
    Direxion Daily Dow Jones Internet Bear 3X Shares
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 34.66% over the past day.

Buy
63
SKX alert for May 7

Skechers USA [SKX] is down 0.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock